Investment company Spiros Segalas buys Activision Blizzard Inc, Broadcom, Nike Inc, Crown Castle International Corp, Netflix Inc, Allergan PLC, Illumina Inc, Bristol-Myers Squibb Company, Biomarin Pharmaceutical Inc, Regeneron Pharmaceuticals Inc, sells Starbucks Corp, TJX Inc, Halliburton Co, S&P Global Inc, NXP Semiconductors NV during the 3-months ended 2017-04-30, according to the most recent filings of the investment company, Harbor Capital Appreciation Fund. As of 2017-04-30, Harbor Capital Appreciation Fund owns 58 stocks with a total value of $26.1 billion. These are the details of the buys and sells.
For the details of Spiros Segalas's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Spiros+Segalas
These are the top 5 holdings of Spiros SegalasApple Inc (AAPL) - 11,000,132 shares, 6.06% of the total portfolio. Shares added by 13.54%Amazon.com Inc (AMZN) - 1,414,503 shares, 5.02% of the total portfolio. Shares reduced by 17.59%Facebook Inc (FB) - 7,640,347 shares, 4.41% of the total portfolio. Shares added by 7.32%Microsoft Corp (MSFT) - 13,919,247 shares, 3.66% of the total portfolio. Shares added by 4.01%Alibaba Group Holding Ltd (BABA) - 7,679,282 shares, 3.4% of the total portfolio. Shares reduced by 2.92%New Purchase: Activision Blizzard Inc (ATVI)Spiros Segalas initiated holdings in Activision Blizzard Inc. The purchase prices were between $39.19 and $52.25, with an estimated average price of $47.35. The stock is now traded at around $58.09. The impact to the portfolio due to this purchase was 1.21%. The holdings were 6,040,016 shares as of 2017-04-30.
Top 5 Value Stocks To Invest In Right Now: MKS Instruments, Inc.(MKSI)
Advisors' Opinion:- [By Stephan Byrd]
MKS Instruments, Inc. (NASDAQ:MKSI) Director Richard S. Chute sold 1,988 shares of the firm’s stock in a transaction that occurred on Wednesday, May 9th. The shares were sold at an average price of $110.75, for a total value of $220,171.00. Following the completion of the sale, the director now directly owns 10,103 shares of the company’s stock, valued at $1,118,907.25. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.
- [By Logan Wallace]
MKS Instruments, Inc. (NASDAQ:MKSI) Director Peter Hanley sold 250 shares of the business’s stock in a transaction dated Friday, May 11th. The shares were sold at an average price of $113.70, for a total transaction of $28,425.00. Following the completion of the transaction, the director now owns 3,241 shares in the company, valued at $368,501.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Top 5 Value Stocks To Invest In Right Now: PennyMac Mortgage Investment Trust(PMT)
Advisors' Opinion:- [By Stephan Byrd]
Pennymac Mortgage Investment (NYSE:PMT) – Equities researchers at Wedbush lifted their Q1 2019 earnings per share estimates for shares of Pennymac Mortgage Investment in a research note issued to investors on Thursday, May 10th. Wedbush analyst J. Weaver now anticipates that the real estate investment trust will post earnings per share of $0.36 for the quarter, up from their previous estimate of $0.34. Wedbush also issued estimates for Pennymac Mortgage Investment’s Q2 2019 earnings at $0.43 EPS, Q3 2019 earnings at $0.43 EPS, Q4 2019 earnings at $0.52 EPS and FY2019 earnings at $1.74 EPS.
Top 5 Value Stocks To Invest In Right Now: Navistar International Corporation(NAV)
Advisors' Opinion:- [By Ethan Ryder]
NavCoin (CURRENCY:NAV) traded up 3.1% against the US dollar during the 24 hour period ending at 12:00 PM ET on May 14th. NavCoin has a market cap of $69.58 million and approximately $924,266.00 worth of NavCoin was traded on exchanges in the last day. Over the last week, NavCoin has traded 12.8% lower against the US dollar. One NavCoin coin can now be bought for $1.11 or 0.00012616 BTC on cryptocurrency exchanges including LiteBit.eu, Upbit, cfinex and Poloniex.
- [By Paul Ausick]
While the transition period from one chief executive officer to another has barely gotten started at Volkswagen, some big changes may already be afoot. VW’s commercial-vehicles unit, Volkswagen Truck & Bus, is looking at the possibility of buying more shares in U.S. truck maker Navistar International Corp. (NYSE: NAV) or even acquiring the whole company outright.
Top 5 Value Stocks To Invest In Right Now: Merit Medical Systems Inc.(MMSI)
Advisors' Opinion:- [By Max Byerly]
Eagle Boston Investment Management Inc. increased its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 5.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 412,344 shares of the medical instruments supplier’s stock after buying an additional 20,334 shares during the quarter. Merit Medical Systems comprises approximately 1.9% of Eagle Boston Investment Management Inc.’s holdings, making the stock its 4th largest position. Eagle Boston Investment Management Inc. owned 0.82% of Merit Medical Systems worth $18,699,000 at the end of the most recent reporting period.
Top 5 Value Stocks To Invest In Right Now: bluebird bio, Inc.(BLUE)
Advisors' Opinion:- [By Stephan Byrd]
bluebird bio (NASDAQ:BLUE)‘s stock had its “underweight” rating reaffirmed by equities research analysts at Cantor Fitzgerald in a report issued on Wednesday.
- [By Rafi Farber]
Here��s some perspective. Within the past decade, University of Pennsylvania has allied with Novartis A.G. (NYSE: NVS), Baylor College of Medicine with Bluebird Bio Inc. (NASDAQ: BLUE) and Celgene Corp. (NASDAQ:�CELG), Memorial Sloan Kettering Cancer Center and the Fred Hutchinson Cancer Research Center with Juno Therapeutics Inc. (NASDAQ: JUNO) (which Celgene just got clearance to acquire), and the National Cancer Institute with Kite Pharma, which was acquired last year by�Gilead Sciences Inc. (NASDAQ: GILD).
- [By Brian Orelli]
�bluebird bio (NASDAQ:BLUE) reported�first-quarter earnings last week, but like the biotech typically does, management didn't hold a conference call, which makes the earnings release more of a rehash of the quarter than an actual update.
- [By Todd Campbell, Leo Sun, and Daniel Miller]
For instance, the company recently acquired Juno Therapeutics to get its hands on a pipeline of chimeric antigen receptor T-cell gene therapies (CAR-Ts). CAR-Ts represent one of the biggest recent advances in treating blood cancer, and depending on trial results, the first CAR-T from this collaboration could be filed for approval next year. Similarly, Celgene is partnering with bluebird bio (NASDAQ:BLUE) on bb2121, a CAR-T for multiple myeloma. So far, bb2121 is delivering 90%-plus response rates in heavily pre-treated patients, and if that success continues, it could end up on regulators' desk for approval next year, too.
- [By Ethan Ryder]
Blue Protocol (CURRENCY:BLUE) traded down 9.1% against the U.S. dollar during the 24-hour period ending at 11:00 AM Eastern on May 12th. One Blue Protocol token can now be purchased for about $0.18 or 0.00002166 BTC on cryptocurrency exchanges including CoinExchange, EtherDelta (ForkDelta), IDEX and YoBit. In the last seven days, Blue Protocol has traded down 16.3% against the U.S. dollar. Blue Protocol has a market capitalization of $6.65 million and $31,443.00 worth of Blue Protocol was traded on exchanges in the last 24 hours.
- [By Stephan Byrd]
bluebird bio (NASDAQ:BLUE) was up 0% during mid-day trading on Thursday . The stock traded as high as $190.50 and last traded at $189.30. Approximately 892,250 shares traded hands during mid-day trading, an increase of 14% from the average daily volume of 779,838 shares. The stock had previously closed at $189.30.
No comments:
Post a Comment